Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Chronic inflammatory bowel disease (CIBD) with its prevalence of 2.6 million people in Europe is diagnosed in 25% before the age of 18 years. Early remission is intended to improve child growth, quality of life and reduce psychological comorbidities. Additionally to conventional drugs one third of pediatric CIBD patients use alternative treatment strategies. However, there is a lack of evidence of acupuncture as complementary medicine in pediatric CIBD on the disease activity and inflammation. Therefore, the main aim of this study is to evaluate the effect of acupuncture in children with CIBD on the Pediatric Ulcerative Colitis Activity Index (PUCAI) and the Weighted Pediatric Crohn's Disease Activity Index (sPCDAI), which are non-invasive validated instruments to measure the disease activity. Furthermore, this study aims to investigate the effect of acupuncture on chronic pain, quality of life and parameters of inflammation.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Control group | No Intervention | 20 CIBD patients do not receive acupuncture or placebo-acupuncture. | |
| Acupuncture group | Active Comparator | 20 CIBD patients receive 8 sessions of acupuncture therapy with 0,3 x 30mm needles (asia-med special number 16). |
|
| Placebo group | Placebo Comparator | 20 CIBD patients receive 8 sessions of sham acupuncture with placebo-needles 0,3 x 30mm (Streitberger). |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Acupuncture | Other | Patients receive 8 acupuncture sessions (1 session per week, 20 minutes per session) with acupuncture needles. |
|
| Measure | Description | Time Frame |
|---|---|---|
| Disease Activity Index | Disease Activity Index (either Paediatric Ulcerative Colitis Activity Index in case of patients with ulcerative colitis or Weighted Pediatric Crohn's Disease Activity in patients with Crohn's disease) | At beginning vs 8 weeks |
| Disease Activity Index | Disease Activity Index (either Paediatric Ulcerative Colitis Activity Index in case of patients with ulcerative colitis or Weighted Pediatric Crohn's Disease Activity in patients with Crohn's disease) | At beginning vs 4 weeks |
| Measure | Description | Time Frame |
|---|---|---|
| Quality of Life in Children and Adolescents measured by KINDL(R) | The quality of life will be measured using the KINDL(R) questionnaire. The data will be transformed according to the manual of the questionnaire. The total score of quality of life ranges from 0 to 100. A higher score is associated with a better quality of life. | At beginning vs 4 weeks |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Gisela Scharbert, MD | MedUniVienna | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Department of Anesthesia, General Intensive Care and Pain Management,Medical University of Vienna | Vienna | 1090 | Austria |
Not provided
| ID | Term |
|---|---|
| D003424 | Crohn Disease |
| D003093 | Colitis, Ulcerative |
| ID | Term |
|---|---|
| D015212 | Inflammatory Bowel Diseases |
| D005759 | Gastroenteritis |
| D005767 | Gastrointestinal Diseases |
| D004066 | Digestive System Diseases |
Not provided
Not provided
| ID | Term |
|---|---|
| D015670 | Acupuncture Therapy |
| ID | Term |
|---|---|
| D000529 | Complementary Therapies |
| D013812 | Therapeutics |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Placebo-Acupuncture | Other | Patients receive 8 acupuncture sessions (1 session per week, 20 minutes per session) with placebo-needles. |
|
| Quality of Life in Children and Adolescents measured by KINDL(R) | The quality of life will be measured using the KINDL(R) questionnaire. The data will be transformed according to the manual of the questionnaire. The total score of quality of life ranges from 0 to 100. A higher score is associated with a better quality of life. | At beginning vs 8 weeks |
| Quality of Life in Children and Adolescents measured by ILK | The quality of life will be also measured using the ILK questionnaire (Inventar zur Erfassung der Lebensqualität bei Kindern und Jugendlichen). The total score of quality ranges from 0 to 28. A higher score is associated with a better quality of life. | At beginning vs 4 weeks |
| Quality of Life in Children and Adolescents measured by ILK | The quality of life will be also measured using the ILK questionnaire (Inventar zur Erfassung der Lebensqualität bei Kindern und Jugendlichen). The total score of quality ranges from 0 to 28. A higher score is associated with a better quality of life). | At beginning vs 8 weeks |
| Pain assessment | The pain will be measured using the numerating scale, which ranges from 0 (no pain) to 10 (worst pain possible). | At beginning vs 4 weeks |
| Pain assessment | The pain will be measured using the numerating scale, which ranges from 0 (no pain) to 10 (worst pain possible). | At beginning vs 8 weeks |
| C reactive protein | As one parameter of inflammation the C reactive protein will be measured in mg/dl. | At beginning vs 4 weeks |
| C reactive protein | As one parameter of inflammation the C reactive protein will be measured in mg/dl. | At beginning vs 8 weeks |
| Leukocytes | As another parameter of inflammation the leukocytes will be measured in 10^9/L | At beginning vs 4 weeks |
| Leukocytes | As another parameter of inflammation the leukocytes will be measured in 10^9/L | At beginning vs 8 weeks |
| Erythrocyte sedimentation rate | As another inflammatory parameter the erythrocyte sedimentation rate (mm/hour) will be measured. | At beginning vs 4 weeks |
| Erythrocyte sedimentation rate | As another inflammatory parameter the erythrocyte sedimentation rate (mm/hour) will be measured. | At beginning vs 8 weeks |
| D007410 | Intestinal Diseases |
| D003092 | Colitis |
| D003108 | Colonic Diseases |